MLA
DNA icon

My Legacy Advisors’s Ginkgo Bioworks DNA Stock Holding History

My Legacy Advisors’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-625
Closed -$33.5K – 214
2023
Q4 		$33.5K Hold
625
– – 0.01% 204
2023
Q3 		$39K Hold
625
– – 0.02% 199
2023
Q2 		$54K Buy
+625
New +$37K 0.02% 210

Other funds holding DNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

My Legacy Advisors's DNA Position: Q1 2024 in Review

My Legacy Advisors sold out of Ginkgo Bioworks (DNA) in Q1 2024, closing a stake of 625 shares — an estimated $33.5K sold.

My Legacy Advisors first reported a position in DNA in Q2 2023 and held it in 3 quarters. The position peaked at $54K in Q2 2023. 342 funds tracked by Wall St. Rank hold DNA as of Q1 2024.

  • My Legacy Advisors reported no remaining Ginkgo Bioworks position as of Q1 2024 after selling out during the quarter.
  • My Legacy Advisors sold 625 Ginkgo Bioworks shares in Q1 2024, an estimated $33.5K.
  • My Legacy Advisors first reported a position in Ginkgo Bioworks in Q2 2023 and held it in 3 quarters.
  • My Legacy Advisors's Ginkgo Bioworks position peaked at $54K in Q2 2023.
  • 342 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q1 2024.

Based on My Legacy Advisors's 13F filing for Q1 2024, filed 25 Jul 2024.